George Sellers

Stock Analyst at Stephens & Co.

(1.07)
# 3,901
Out of 5,113 analysts
44
Total ratings
29.41%
Success rate
-6.52%
Average return

Stocks Rated by George Sellers

Glaukos
Jan 2, 2026
Maintains: Overweight
Price Target: $115$145
Current: $118.70
Upside: +22.16%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $64.95
Upside: +4.70%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275$290
Current: $104.52
Upside: +177.46%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56$58
Current: $36.53
Upside: +58.77%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151$178
Current: $138.49
Upside: +28.53%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.16
Upside: +162.01%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $21.98
Upside: +227.57%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8$5
Current: $4.19
Upside: +19.33%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $2.54
Upside: +884.25%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $19.04
Upside: +199.37%